EUVIMEDObjevte EUVIMED
Übersichtsarbeit

Unveiling the crucial role of intercellular adhesion molecule‐1 in secondary diabetic complications

Prabhnain Kaur, Ritu Dahiya, Mukesh Nandave, Kalicharan Sharma, Ramesh K Goyal

Cell Biochemistry and Function · 2024-06 · 42 (4)

DOI: 10.1002/cbf.4037 ↗

At a glance

Übersichtsarbeit in Cell Biochemistry and Function, published online on 2024-05-12. Written by Prabhnain Kaur and 4 co-authors. Institution: Department of Pharmacology, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, New Delhi, India. Major MEDLINE topics: Intercellular Adhesion Molecule-1. Cited 12 times so far (Crossref); 103 references. Funded by: Indian Council of Medical Research.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Diabetes mellitus is associated with secondary complications such as diabetic retinopathy (DR), nephropathy (DN), and cardiomyopathy (DCM), all of which significantly impact patient health. Intercellular adhesion molecule‐1 (ICAM‐1) has been implicated in inflammatory responses and endothelial dysfunction, both crucial in the pathogenesis of these complications. The goal of this review is to investigate at potential therapy methods that target ICAM‐1 pathways and to better understand the multifaceted role of ICAM‐1 in secondary diabetic problems. A meticulous analysis of scholarly literature published globally was conducted to examine ICAM‐1involvement in inflammatory processes, endothelial dysfunction, and oxidative stress related to diabetes and its complications. Elevated ICAM‐1 levels are strongly associated with augmented leukocyte adhesion, compromised microvascular function, and heightened oxidative stress in diabetes. These pathways contribute significantly to DR, DN, and DCM pathogenesis, highlighting ICAM‐1 as a key player in their progression. Understanding ICAM‐1 role in secondary diabetic complications offers insights into novel therapeutic strategies. Targeting ICAM‐1 pathways may mitigate inflammation, improve endothelial function, and ultimately attenuate diabetic complications, thereby enhancing patient health outcomes. Continued research in this area is crucial for developing effective targeted therapies.

Subjects

MeSH terms (MEDLINE)

Intercellular Adhesion Molecule-1HumansDiabetes ComplicationsOxidative StressAnimalsDiabetic NephropathiesInflammationDiabetic Retinopathy

Author keywords

ICAM‐1cardiomyopathydiabetes mellitusdiabetic retinopathynephropathy

Substances

Intercellular Adhesion Molecule-1

Authors and institutions

  • Department of Pharmacology, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, New Delhi, India.
  • Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga, India.

Funding

  • Indian Council of Medical Research

Cite

APA

Kaur, P., Dahiya, R., Nandave, M., Sharma, K., & Goyal, R. K. (2024). Unveiling the crucial role of intercellular adhesion molecule‐1 in secondary diabetic complications. Cell Biochemistry and Function, 42(4). https://doi.org/10.1002/cbf.4037

Vancouver

Kaur P, Dahiya R, Nandave M, Sharma K, Goyal RK. Unveiling the crucial role of intercellular adhesion molecule‐1 in secondary diabetic complications. Cell Biochemistry and Function. 2024;42(4). doi:10.1002/cbf.4037

BibTeX
@article{Kaur2024,
  author = {Kaur, Prabhnain and Dahiya, Ritu and Nandave, Mukesh and Sharma, Kalicharan and Goyal, Ramesh K},
  title = {Unveiling the crucial role of intercellular adhesion molecule‐1 in secondary diabetic complications},
  journal = {Cell Biochemistry and Function},
  year = {2024},
  volume = {42},
  number = {4},
  doi = {10.1002/cbf.4037}
}
Start for free →